From the drug itself, febuxostat lowering uric acid effect is relatively good, but because of individual differences, febuxostat lowering uric acid effect is good for some patients, but for some patients lowering uric acid effect is poor. Febuxostat tablets are more suitable for long-term treatment of hyperuricemia in gout patients, but not recommended for hyperuricemia without clinical symptoms. Febuxostat tablets belong to the xanthine oxidase inhibitors, belong to a new generation of uric acid drugs, and compared with the more traditional uric acid drugs faster, and the effect is more stable, can effectively inhibit the synthesis of uric acid, from the drug itself, the effect of febuxostat lowering uric acid is relatively good. However, due to individual differences, febuxostat is effective in lowering uric acid in some patients, but is ineffective in lowering uric acid in some patients. Therefore, there is no uniform answer to the effect of Febuxostat in lowering uric acid. When using Febuxostat tablets to lower uric acid, transient mild to moderate reactions, such as blurred vision, neutropenia, pancytopenia, splenomegaly and other adverse reactions may occur. It is contraindicated in persons with a history of hypersensitivity to the components of this product. This product is contraindicated in patients undergoing treatment with azathioprine and mercaptopurine. When the body has hyperuricemia and needs to be treated with febuxostat tablets, it is recommended to consult the rheumatology and immunology department in time and use the medication under the guidance of the doctor, and it is not recommended that the patient use it blindly.